Abstract: BACKGROUND: Staphylococcus aureus-infected patients treated with antibiotics that are effective in vitro often experience relapse of infection because the bacteria hide in privileged locations. These locations include abscesses and host cells, which contain low-pH compartments and are sites from which nonstable S. aureus small-colony variants (SCVs) are frequently recovered. METHODS: We assessed the effect of low pH on S. aureus colony phenotype and bacterial growth, using in vitro and in vivo models of long-term infection. RESULTS: We showed that low pH induced nonstable SCVs and nonreplicating persisters that are capable of regrowth. Within host cells, S. aureus was located in phagolysosomes, a low-pH compartment. Therapeutic neutralization of phagolysosomal pH with ammonium chloride, bafilomycin A1, or the antimalaria drug chloroquine reduced SCVs in infected host cells. In a systemic mouse infection model, treatment with chloroquine also reduced SCVs. CONCLUSIONS: Our results show that the acidic environment favors formation of nonstable SCVs, which reflect the SCVs found in clinics. They also provide evidence that treatment with alkalinizing agents, together with antibiotics, may provide a novel translational strategy for eradicating persisting intracellular reservoirs of staphylococci. This approach may also be extended to other intracellular bacteria. 
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Introduction
The human pathogen Staphylococcus aureus colonizes approximately a third of all humans and is one of the leading causes of bacteremia and infective endocarditis in the industrialized world [1] . In addition to emerging antibiotic resistance, persisting and recurrent infections substantially add to morbidity and mortality [2, 3] . Recurrence rates, in particular after osteomyelitis or endocarditis, are high and infections may relapse even years after apparent cure [4] .
Infection recurrence is associated with non-stable SCVs and/or non-replicating persisters for several reasons [5] [6] [7] [8] . Their arrested or slow growth and reduced metabolism renders antibiotics inefficient [9] [10] [11] [12] [13] . Moreover, they preferentially hide in privileged locations such as in abscesses and within host cells [14] [15] [16] [17] . These privileged locations shield them from the host's innate immune system and from extracellularly active antibiotics. In addition, antibiotics do not penetrate abscesses efficiently and are less active due to the low pH [18] [19] [20] [21] [22] . Therefore the 'ubi pus ibi evacua' -the necessity of surgical removal of abscesses formulated in the antiquity still applies nowadays despite highly active antibiotics. In contrast to abscesses, intracellular bacteria cannot be mechanically removed and often resist eradication by currently available antibiotics.
Most SCVs isolated in clinical microbiology laboratories revert to the large colony phenotype upon sub-cultivation. Due to these non-stable properties, stable genetically-modified SCV mutants with defects in the electron transport system have been used to find new strategies to The Staphylococcus aureus strains used in this study are listed in Table 1 . S. aureus was grown in LB Lennox broth (BD Biosciences) at 37 °C, shaking or on Columbia agar + 5 % sheep blood plates (BioMérieux).
Media with adjusted pH (pH 4.0, 5.5, 6.5 and 7.4) were prepared with DMEM (4.5 g/ml Glucose, without Phenolred, Pyruvat and L-Glutamine, Life Technologies) supplemented with 10 % FBS and 4 mM of L-Glutamine (Life Technologies). The pH 4.0, 5.5 and 6.5 media were prepared with buffers (containing Na 2 HPO 4 and citric acid, both from Fluka) of pH 2.6, 4.0 and 5.6, respectively and were mixed at a ratio of 3:7 with DMEM. pH 7.4 was maintained by 50 mM
HEPES (Life Technologies).
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Intracellular persistence model
A549 cells (1 x 10 6 ) were seeded into the wells of a 12 well plate in 1 ml medium. Cells were infected as described previously with minor modifications [14] . Briefly, cells were infected with S.
aureus Cowan at a multiplicity of infection (MOI) of 1 or 100 for intracellular persistence assays and microscopy, respectively. Three hours post-infection, cells were washed with Dulbecco's Phosphate Buffered Saline (DPBS, Life Technologies) and Flucloxacillin (Actavis, 1 mg/ml in DMEM + 10 % FBS) was added in DMEM for 2 hours to kill any extracellular bacteria.
Supernatants were monitored for sterility by plating an aliquot on agar plates. Flucloxacillincontaining media were supplemented with lysosomotropic alkalinizing agents (20 µM chloroquine, 1 nM bafilomycin A1, 5 mM ammonium chloride, all from Sigma). Flucloxacillin-A c c e p t e d M a n u s c r i p t 7 containing media without lysosomotropic alkalinizing agents served as controls. The washing step was repeated and fresh medium was added to the cells daily.
After extensive washing with DPBS, host cells were lysed (0.08 % Triton X-100 from Fluka in DPBS) and serial-fold dilutions of the cell lysates were plated onto blood agar plates to detect intracellular persisting bacteria. CFUs were enumerated and the colony phenotype determined.
To assess cell damage induced by S. aureus or by lysosomotropic alkalinizing agents, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were performed as previously described [27] . Non-infected, non-treated cells served as 100 % cell viability control.
Fluorescence staining and confocal microscopy
Bacteria were labeled with Carboxy-Fluorescein diacetate Succinimidyl Ester (CFSE, Life 
Deconvolution was done with Huygens software (SVI).
To assess the pH of phagolysosomes, A549 cells treated with flucloxacillin only or supplemented with lysosomotropic alkalinizing agents were stained with 5 µg/ml acridine orange (Sigma) for 15min and analyzed by confocal microscopy [28] .
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Scanning Electron Microscopy
Bacteria grown on agar plates or in liquid media were fixed with 2.5 % glutaraldehyde in DPBS and harvested onto glass slides using a cytospin (3 min, 1000 rpm). After incubation in 1 % osmium tetroxide, bacteria were dehydrated with an increasing concentration of ethanol (70-100%), critical-point dried (Bal Tec CPD 030, Leica) and coated with 5 nm of platinum in a sputtering device (Bal Tec SCD 500, Leica). The samples were examined with a field emission scanning electron microscope (SUPRA 50 VP, Zeiss) using the in-lens detector.
Transmission Electron Microscopy
Infected A549 cells were fixed with 2.5% glutaraldehyde and 1% formaldehyde in DPBS. After incubation in 1 % osmium tetroxide and staining with 1% uranyl acetate, cells were embedded in resin. Ultrathin sections (70 nm in thickness) were prepared using an ultramicrotome (Ultracut E, Reichert), collected on slot copper grids and stained with Reynolds lead citrate. The sections were examined using a Philips CM100 transmission electron microscope equipped with a side mounted digital camera (4k x 3k, Gatan).
Ethics Statement
Mice were purchased from Janvier, France, and handled in accordance with the Figure 1) . Thus, we showed a clear correlation between low pH and non-stable SCV formation. This method permitted easy and controlled formation of non-stable, non-genetically modified SCVs in various S. aureus strains.
Induction of non-replicating S. aureus by low pH
The pH-dependent growth of S. aureus Cowan was followed over time by labeling the bacterial Scanning electron microscopy (SEM) of bacteria originating from a small colony (Figure 1C) , obtained under low-pH conditions, showed impaired cell division resulting in rod-shaped S.
aureus, in contrast to large colony bacteria showing normal cell division (Figure 1C, arrows) .
Growth resumption of low pH-adapted S. aureus persisters
Our findings indicated that both, SCVs and non-replicating persisters, are induced by low pH. In clinical practice, the presence of these persisting bacteria correlate with increased recurrence of infection which implies that bacteria revert to a highly virulent and fast-growing form [14] . We therefore tested in vitro whether low pH-induced SCVs and/or non-replicating persisters can restore normal growth in neutral pH. Non-replicating S. aureus persisters were induced and kept at pH 4.0 for three days and then transferred to pH 4.0, 5.5, 6.5 or 7.4 growth media. Bacteria in pH 7.4 and 6.5 resumed growth after approximately 12 hours ( Figure 1D ) whereas bacteria kept at low pHs (< 6.5) remained in a non-proliferating state ( Figure 1D ). The bacteria transferred to pH 7.4 growth medium had a large colony phenotype after eleven hours ( Supplementary   Figures 2A-C) . These data suggest that both persisting phenotypes were reversible adaptions to low pH as supported by the capability of regrowth and phenotype switch to the fast-growing form upon neutralization of pH.
Intracellular induction of S. aureus SCVs
We investigated whether internalized S. aureus exhibited a SCV phenotype. MSSA strain Cowan is highly invasive, but not cytotoxic [31] 
Reduction of S. aureus SCVs through phagolysosomal alkalinization
Since low pH induced SCVs and/or non-replicating S. aureus and medium pH neutralization 
Discussion
This study showed that low pH, as found in abscesses and within lysosomes, induced the persisting S. aureus subpopulations SCVs and non-replicating persisters. Raising pH in the culture medium or within the phagolysosomes using alkalinizing agents reverted S. aureus to normal growth.
SCV formation was shown to be triggered by antibiotic pressure [32] . In addition, extreme environmental stresses such as prolonged exposure to low temperature, very acidic or alkaline environments, or osmotic stress may trigger SCV and/or persister formation in S. aureus and coagulase-negative staphylococci [33] . These observations, together with our new findings,
show how multiple stimuli lead to S. aureus persister formation. Localization within the host cell shields S. aureus from commonly used antibiotics such as the extracellularly active beta-lactams with poor cell penetration [34] . In addition, the low intraphagolysosomal pH renders antibiotics with intracellular activity such as clindamycin and fluoroquinolones less active [20, 35] . We found that the addition of lysosomotropic alkalinizing agents to the usually prescribed antibiotics such as flucloxacillin reduced the frequency of S. aureus SCVs in vitro as well as in vivo. We thus identified a simple strategy to circumvent the host-dependent component of S. aureus persister formation. In clinical settings, the presence of SCVs in osteomyelitis and device-related A c c e p t e d M a n u s c r i p t 13 infections has been associated with increased relapse rates, despite administration of antibiotics [5, 35, 36] . Bacteria adapt to antibiotic stress by SCV and/or persister formation [32] . We now showed that S. aureus SCVs and non-replicating persisters retained the ability to revert to a highly virulent and fast-growing form. The capacity to revert to fast growth (phenotype switching) results in relapsing infection. In addition, it renders identification of SCVs difficult. Further aggravating the SCV problem is the underestimation of SCVs in clinical microbiology laboratories, since they form tiny and thus difficult to detect colonies which are easily overgrown by their fast growing counterparts [37] .
We postulate that the addition of alkalinizing agents to the usually prescribed antibiotics will reduce the frequency of SCVs and could therefore reduce recurrence rates in the future.
Chloroquine should also be considered in combination with vancomycin, a drug that has been shown to have reduced activity against SCVs [38] . This could, at least in part, explain the high relapse rates associated with vancomycin [39] . However, this strategy cannot eradicate extracellularly persisting bacteria as found in abscesses or biofilms as chloroquine acts specifically on lysosomes. Surgery and antibiotics will remain the treatment of choice for these.
Even though we show a clear correlation between low pH and non-stable SCV formation, the underlying mechanism remains to be elucidated. Whether low pH acts as a trigger and induces the formation of new SCVs or whether low pH rather acts as a selective pressure and enriches preexisting SCVs is unclear. Yet, the therapeutic strategy of phagolysosomal alkalinization employed acts on SCVs in general, i.e. on the preexisting SCVs, as well as on newly formed SCVs.
Persisting bacteria are not unique to S. aureus but have also been described to occur in various other human pathogens, such as Salmonella spp., Pseudomonas aeruginosa, Escherichia coli
and Mycobacterium tuberculosis [5, [40] [41] [42] . In addition to low pH, bacterial persisters can arise due to mechanisms that include the toxin-antitoxin systems [43, 44] . Accordingly, activation of a SOS response (ppGpp) in response to DNA damage due to oxidative stress results in decreased A c c e p t e d M a n u s c r i p t 14 ATP levels [45, 46] . This leads to the shutdown of metabolism resulting in reduced growth.
Various toxin-antitoxin modules are activated by acidification and/or nutrient starvation in Salmonella, causing formation of persisters [47] . In accordance with our findings, Salmonella persister formation has been reported in macrophages triggered by the acidic and nutritionally poor environment of the Salmonella-containing vacuole that was reversible by addition of bafilomycin A1 [47] . In contrast to bafilomycin A1, chloroquine is routinely used in patients to treat malaria as well as some rheumatic diseases. Phagolysosomal pH neutralization with chloroquine may therefore provide a novel therapeutic eradication strategy against intracellular persisting staphylococcal reservoirs. Already, phagolysosomal alkalinization by chloroquine has proven to be an effective strategy for eradicating the obligate intracellular bacterium Coxiella burnetii, the pathogen responsible for Q fever [48] . Phagolysosomal alkalinization restored the activity of intracellular antibiotics resulting in Coxiella burnetii clearance. It is tempting to propose that our findings may be applicable to other intracellularly persisting bacterial infections. peritoneal lavage. Two-way ANOVA found the factor treatment to be significant (p-value < 0.01).
